Skip to content

Clinical trials

Lymphangioleiomyomatosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphangioleiomyomatosis Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20052
20062
20071
20093
20101
20111
20123
20132
20142
20151
20165
20172
20185
20193
20201
20213
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting10
Unknown status5
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
University of Cincinnati5
Brigham and Women's Hospital3
Novartis Pharmaceuticals3
Children's Hospital Medical Center, Cincinnati2
Peking Union Medical College Hospital2
CENTOGENE GmbH Rostock1
Cardiff University1
Columbia University1
David M. Ritter1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphangioleiomyomatosis48
Tuberous Sclerosis16
Angiomyolipoma5
Lung Diseases3
Ascites2
Asthma2
Astrocytoma2
Hereditary Sensory and Autonomic Neuropathies2
Lymphangiomyoma2
Pneumothorax2

Trials

Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.